Caris Life Sciences, Inc. (CAI)
NASDAQ: CAI · Real-Time Price · USD
30.19
-1.09 (-3.50%)
At close: Jul 18, 2025, 4:00 PM
29.90
-0.29 (-0.96%)
After-hours: Jul 18, 2025, 7:49 PM EDT
Company Description
Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms.
The company’s molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment.
It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.
The company was founded in 2008 and is headquartered in Irving, Texas.
Caris Life Sciences, Inc.
| Country | United States |
| Founded | 2008 |
| IPO Date | Jun 18, 2025 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,769 |
| CEO | David Halbert |
Contact Details
Address: 750 West John Carpenter Freeway, Suite 800 Irving, Texas 75039 United States | |
| Phone | 866 771 8946 |
| Website | carislifesciences.com |
Stock Details
| Ticker Symbol | CAI |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $21.00 |
| CIK Code | 0002019410 |
| CUSIP Number | 12477X106 |
| ISIN Number | US12477X1063 |
| Employer ID | 85-2077369 |
| SIC Code | 8071 |
Key Executives
| Name | Position |
|---|---|
| David D. Halbert, D.Sc. (h.c.) | Founder, Chairman, and Chief Executive Officer |
| Brian J. Brille | Vice Chairman and Executive Vice President |
| David Spetzler, M.S., Ph.D., M.B.A. | President |
| Luke Power | Senior Vice President, Chief Financial Officer, and Chief Accounting Officer |
| J. Russel Denton | Senior Vice President, General Counsel, and Secretary |
| George H. Poste, D.V.M., Ph.D., D.Sc., F.R.S. | Vice Chairman |
| Jonathan Knowles, Ph.D. | Vice Chairman |
| Nathan Burns | Director |
| Peter M. Castleman | Director |
| David Fredrickson | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jun 24, 2025 | SCHEDULE 13G | Filing |
| Jun 20, 2025 | 8-K | Current Report |
| Jun 20, 2025 | 424B4 | Prospectus |
| Jun 18, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |
| Jun 17, 2025 | EFFECT | Notice of Effectiveness |
| Jun 17, 2025 | CERT | Certification by an exchange approving securities for listing |
| Jun 16, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| Jun 13, 2025 | 8-A12B | Registration of securities |
| Jun 9, 2025 | S-1/A | [Amend] General form for registration of securities under the Securities Act of 1933 |
| May 23, 2025 | S-1 | General form for registration of securities under the Securities Act of 1933 |